Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07536399
PHASE3

Biologic Augmentation of TMJ Arthroscopy Using BMAC

Sponsor: Weill Medical College of Cornell University

View on ClinicalTrials.gov

Summary

The goal of this clinical trial is to learn about the efficacy of using Bone Marrow Aspirate Concentrate (BMAC) during temporomandibular joint (TMJ) arthroscopy compared to standard arthroscopic procedures with corticosteroid (CS) injections in patients with pain (arthralgia) of the temporomandibular joint (TMJ) that has failed to respond to conservative treatment. The main question it aims to answer: Does BMAC injection reduce the amount of inflammation and structural damage in the TMJ? Researchers will compare BMAC injection to corticosteroid injections see if BMAC injection helps . Participants will : * Be randomized to receive either BMAC or CS injection during TMJ arthroscopy * Visit the clinic for 3 follow up visits over 6 months and answer questionnaires * have 2 MRIs of their jaw

Official title: Biologic Augmentation of Temporomandibular Joint Arthroscopy Using Bone Marrow Aspirate Concentrate (BMAC): A Proposed Clinical Trial

Key Details

Gender

All

Age Range

18 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

20

Start Date

2026-04

Completion Date

2028-06

Last Updated

2026-04-17

Healthy Volunteers

No

Interventions

BIOLOGICAL

Bone Marrow Aspirate Concentrate

Single dose injection of bone marrow fluid from the participant's anterior iliac crest (hip) into the TMJ area during arthroscopy.

DRUG

Corticosteroid (CS)

Single dose injection of cortiosteroid into the TMJ area during arthroscopy.

Locations (1)

Weill Cornell Medical College - NewYork-Presbyterian Hospital

New York, New York, United States